Toward Better Therapy for Lymphoma and MyelomaFISHER, Richard I; RICHARDSON, Paul G.Journal of clinical oncology. 2011, Vol 29, Num 14, issn 0732-183X, 139 p.Serial Issue

Transformation of Indolent B-Cell LymphomasMONTOTO, Silvia; FITZGIBBON, Jude.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1827-1834, issn 0732-183X, 8 p.Article

Pathogenesis of Non-Hodgkin's LymphomaNOGAI, Hendrik; DÖRKEN, Bernd; LENZ, Georg et al.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1803-1811, issn 0732-183X, 9 p.Article

Allogeneic Transplantation for LymphomaCHAKRAVERTY, Ronjon; MACKINNON, Stephen.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1855-1863, issn 0732-183X, 9 p.Article

Amyloidosis: Pathogenesis and New Therapeutic OptionsMERLINI, Giampaolo; SELDIN, David C; GERTZ, Morie A et al.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1924-1933, issn 0732-183X, 10 p.Article

Role of Functional Imaging in the Management of LymphomaCHESON, Bruce D.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1844-1854, issn 0732-183X, 11 p.Article

Long-Term Complications of Lymphoma and Its TreatmentNG, Andrea K; LACASCE, Ann; TRAVIS, Lois B et al.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1885-1892, issn 0732-183X, 8 p.Article

Advances in Imaging and the Management of Myeloma Bone DiseaseTERPOS, Evangelos; MOULOPOULOS, Lia A; DIMOPOULOS, Meletios A et al.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1907-1915, issn 0732-183X, 9 p.Article

Molecular Heterogeneity of Multiple Myeloma: Pathogenesis, Prognosis, and Therapeutic ImplicationsAVET-LOISEAU, Hervé; MAGRANGEAS, Florence; MOREAU, Philippe et al.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1893-1897, issn 0732-183X, 5 p.Article

Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the MicroenvironmentSTEIDL, Christian; CONNORS, Joseph M; GASCOYNE, Randy D et al.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1812-1826, issn 0732-183X, 15 p.Article

Active and Passive Immunotherapy for Lymphoma: Proving Principles and Improving ResultsBRODY, Joshua; KOHRT, Holbrook; MARABELLE, Aurelien et al.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1864-1875, issn 0732-183X, 12 p.Article

Novel Therapeutics for Aggressive Non-Hodgkin's LymphomaMAHADEVAN, Daruka; FISHER, Richard I.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1876-1884, issn 0732-183X, 9 p.Article

Current Trends in Autologous Stem-Cell Transplantation for Myeloma in the Era of Novel TherapiesMOREAU, Philippe; AVET-LOISEAU, Hervé; HAROUSSEAU, Jean-Luc et al.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1898-1906, issn 0732-183X, 9 p.Article

Future Directions of Next-Generation Novel Therapies, Combination Approaches, and the Development of Personalized Medicine in MyelomaMITSIADES, Constantine S; DAVIES, Faith E; LAUBACH, Jacob P et al.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1916-1923, issn 0732-183X, 8 p.Article

The Gray Zone Between Burkitt's Lymphoma and Diffuse Large B-Cell Lymphoma From a Genetics PerspectiveSALAVERRIA, Itziar; SIEBERT, Reiner.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1835-1843, issn 0732-183X, 9 p.Article